Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Paprocki

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of the Endocrine Society|January 12, 2024
Distinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary SyndromeAngie Chen-Patterson, Angelina Bernier, Tania Burgert, et al.
Diabetes Care|November 3, 2022
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at ScreeningEmily K Sims, David Cuthbertson, Jamie L Felton, et al.
Journal of Clinical & Translational Endocrinology|June 11, 2024
Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experienceLaya Ekhlaspour, Bruce Buckingham, Colleen Bauza, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of the Endocrine Society|January 12, 2024
Distinct Reproductive Phenotypes Segregate With Differences in Body Weight in Adolescent Polycystic Ovary SyndromeAngie Chen-Patterson, Angelina Bernier, Tania Burgert, et al.
Diabetes Care|November 3, 2022
Persistence of β-Cell Responsiveness for Over Two Years in Autoantibody-Positive Children With Marked Metabolic Impairment at ScreeningEmily K Sims, David Cuthbertson, Jamie L Felton, et al.
Journal of Clinical & Translational Endocrinology|June 11, 2024
Safety and prescribing recommendations for verapamil in newly diagnosed pediatric type 1 diabetes (T1D): The CLVer experienceLaya Ekhlaspour, Bruce Buckingham, Colleen Bauza, et al.
Pageof 2